Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mancuso

Showing results (411-420 of 467) with videos related to

Pageof 47
Sort By:
Clinical and Experimental Obstetrics & Gynecology|March 15, 2003
Complementary therapy for severe Rh-alloimmunizationG Noia, M De Santis, D Romano, et al.
International Journal of Cancer|April 15, 1994
Quercetin enhances transforming growth factor beta 1 secretion by human ovarian cancer cellsG Scambia, P B Panici, F O Ranelletti, et al.
British Journal of Haematology|August 1, 1990
Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoidsL M Larocca, M Piantelli, G Leone, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sitesG Scambia, F O Ranelletti, P Benedetti Panici, et al.
Menopause (New York, N.Y.)|April 4, 2000
Clinical effects of a standardized soy extract in postmenopausal women: a pilot studyG Scambia, D Mango, P G Signorile, et al.
International Journal of Cancer|January 2, 1994
Significance of epidermal growth factor receptor expression in primary human endometrial cancerG Scambia, P Benedetti Panici, G Ferrandina, et al.
International Journal of Cancer|February 1, 1992
Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumorsF O Ranelletti, R Ricci, L M Larocca, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 1998
Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancerP Benedetti-Panici, S Greggi, G Scambia, et al.
Minerva Ginecologica|January 19, 2000
[The antioxidants (coenzyme Q10) in materno-fetal physiopathology]G Noia, D Romano, M De Santis, et al.
Transfusion|May 11, 2001
Peripheral blood progenitor cell collection after epirubicin, paclitaxel, and cisplatin combination chemotherapy using EPO-based cytokine regimens: a randomized comparison of G-CSF and sequential GM-/G-CSFA Perillo, L Pierelli, G Scambia, et al.
Pageof 47

Showing results (411-420 of 467) with videos related to

Sort By:
Pageof 47
Clinical and Experimental Obstetrics & Gynecology|March 15, 2003
Complementary therapy for severe Rh-alloimmunizationG Noia, M De Santis, D Romano, et al.
International Journal of Cancer|April 15, 1994
Quercetin enhances transforming growth factor beta 1 secretion by human ovarian cancer cellsG Scambia, P B Panici, F O Ranelletti, et al.
British Journal of Haematology|August 1, 1990
Type II oestrogen binding sites in acute lymphoid and myeloid leukaemias: growth inhibitory effect of oestrogen and flavonoidsL M Larocca, M Piantelli, G Leone, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Quercetin inhibits the growth of a multidrug-resistant estrogen-receptor-negative MCF-7 human breast-cancer cell line expressing type II estrogen-binding sitesG Scambia, F O Ranelletti, P Benedetti Panici, et al.
Menopause (New York, N.Y.)|April 4, 2000
Clinical effects of a standardized soy extract in postmenopausal women: a pilot studyG Scambia, D Mango, P G Signorile, et al.
International Journal of Cancer|January 2, 1994
Significance of epidermal growth factor receptor expression in primary human endometrial cancerG Scambia, P Benedetti Panici, G Ferrandina, et al.
International Journal of Cancer|February 1, 1992
Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumorsF O Ranelletti, R Ricci, L M Larocca, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 1998
Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancerP Benedetti-Panici, S Greggi, G Scambia, et al.
Minerva Ginecologica|January 19, 2000
[The antioxidants (coenzyme Q10) in materno-fetal physiopathology]G Noia, D Romano, M De Santis, et al.
Transfusion|May 11, 2001
Peripheral blood progenitor cell collection after epirubicin, paclitaxel, and cisplatin combination chemotherapy using EPO-based cytokine regimens: a randomized comparison of G-CSF and sequential GM-/G-CSFA Perillo, L Pierelli, G Scambia, et al.
Pageof 47